Gene · 4102
Papers3,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune System Alterations in Multiple Myeloma: Molecular Mechanisms and Therapeutic Strategies to Reverse Immunosuppression. | Cancers (Basel) | 2021 | 33802806 | PubTator, text mining | PubMed |
| Cardiotoxicity Associated with Anti-CD19 Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Recognition, Risk Factors, and Management. | Diseases | 2021 | 33802788 | PubTator, text mining | PubMed |
| Oncolytic Adenoviruses for Cancer Therapy. | Int J Mol Sci | 2021 | 33802281 | PubTator, text mining | PubMed |
| Cell Therapies in Bladder Cancer Management. | Int J Mol Sci | 2021 | 33802203 | PubTator, text mining | PubMed |
| CD8+ T Cell Responses during HCV Infection and HCC. | J Clin Med | 2021 | 33801203 | PubTator, text mining | PubMed |
| Expedition into Exosome Biology: A Perspective of Progress from Discovery to Therapeutic Development. | Cancers (Basel) | 2021 | 33800282 | PubTator, text mining | PubMed |
| Factors Affecting Extracellular Vesicles Based Drug Delivery Systems. | Molecules | 2021 | 33799765 | PubTator, text mining | PubMed |
| Boosting Immunity against Multiple Myeloma. | Cancers (Basel) | 2021 | 33799565 | PubTator, text mining | PubMed |
| An Overview on the Development of mRNA-Based Vaccines and Their Formulation Strategies for Improved Antigen Expression In Vivo. | Vaccines (Basel) | 2021 | 33799516 | PubTator, text mining | PubMed |
| A phase 1 study of NY-ESO-1 vaccine + anti-CTLA4 antibody Ipilimumab (IPI) in patients with unresectable or metastatic melanoma. | Oncoimmunology | 2021 | 33796406 | PubTator, text mining | PubMed |
| Molecular basis of C-S bond cleavage in the glycyl radical enzyme isethionate sulfite-lyase. | Cell Chem Biol | 2021 | 33773110 | PubTator, text mining | PubMed |
| Extracellular vesicles in immunomodulation and tumor progression. | Nat Immunol | 2021 | 33753940 | PubTator, text mining | PubMed |
| The cancer testis antigens CABYR-a/b and CABYR-c are expressed in a subset of colorectal cancers and hold promise as targets for specific immunotherapy. | Oncotarget | 2021 | 33747357 | PubTator, text mining | PubMed |
| Nuclear overexpression levels of MAGE-A3 predict poor prognosis in patients with prostate cancer. | APMIS | 2021 | 33743542 | PubTator, text mining | PubMed |
| Clinical Significance of a Novel Tumor Progression-Associated Immune Signature in Colorectal Adenocarcinoma. | Front Cell Dev Biol | 2021 | 33732694 | PubTator, text mining | PubMed |
| Exploiting Tumor Neoantigens to Target Cancer Evolution: Current Challenges and Promising Therapeutic Approaches. | Cancer Discov | 2021 | 33722796 | PubTator, text mining | PubMed |
| Clinical and immunological effects of mRNA vaccines in malignant diseases. | Mol Cancer | 2021 | 33722265 | PubTator, text mining | PubMed |
| Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform. | Mol Ther Oncolytics | 2021 | 33718594 | PubTator, text mining | PubMed |
| Hypomethylating Agents and Immunotherapy: Therapeutic Synergism in Acute Myeloid Leukemia and Myelodysplastic Syndromes. | Front Oncol | 2021 | 33718188 | PubTator, text mining | PubMed |
| Molecular biomarkers in early stage lung cancer. | Transl Lung Cancer Res | 2021 | 33718054 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4102/papers?page=46